Antibodies News and Research

RSS

IUPUI researchers are developing a fast, efficient COVID-19 biosensor

As the BA.5 omicron variant continues to spread, health experts are increasingly preparing for a future in which such COVID-19 variants emerge, surge and recede similar to seasonal flu.

21 Jul 2022

LJI study about common cold coronaviruses may offer clues to how immunity can build up against SARS-CoV-2

For a glimpse into the future of SARS-CoV-2 immunity, scientists at La Jolla Institute for Immunology (LJI) are investigating how the immune system builds its defenses against common cold coronaviruses (CCCs).

21 Jul 2022

New AI software can create proteins that may be useful as vaccines, cancer treatments

Scientists have developed artificial intelligence software that can create proteins that may be useful as vaccines, cancer treatments, or even tools for pulling carbon pollution out of the air.

21 Jul 2022

Study may help overcome some obstacles to the development of nanoparticle-based drugs

Using nanoparticles to deliver cancer drugs offers a way to hit tumors with large doses of drugs while avoiding the harmful side effects that often come with chemotherapy.

21 Jul 2022

Alzheimer's disease and anti-amyloid therapeutic approaches

An estimated 50 million people around the world have Alzheimer's disease (AD), and perhaps twice that number are unknowingly "incubating" the disease during its long presymptomatic period.

21 Jul 2022

A different approach to build a more durable, broadly effective COVID-19 vaccine

Researchers at University of California San Diego School of Medicine, with colleagues elsewhere, describe a different way to build a COVID-19 vaccine, one that would, in theory, remain effective against new and emerging variants and could be taken as a pill, by inhalation or other delivery methods.

21 Jul 2022

Are Mexican free-tailed bats a SARS-CoV-2 reservoir?

In a new study, investigators analyzed whether Mexican free-tailed bats were a SARS-CoV-2 reservoir.

21 Jul 2022

Booster vaccination counters the severity of Omicron breakthrough infections

Researchers assessed a panel of seven SARS-CoV-2 vaccines currently available globally and in the United States and immunity acquired through the previous infection against all Omicron subvariants.

21 Jul 2022

Immuno-infrared sensor identifies Alzheimer's disease in the blood up to 17 years in advance

A sensor identifies misfolded protein biomarkers in the blood. This offers a chance to detect Alzheimer's disease before any symptoms occur. Researchers intend to bring it to market maturity.

21 Jul 2022

FDA clears IND application for MD Anderson-sponsored Phase I clinical study of OBX-115 therapy

The University of Texas MD Anderson Cancer Center and Obsidian Therapeutics, Inc. today announced Food and Drug Administration (FDA) clearance of an Investigational New Drug (IND) application for an MD Anderson-sponsored Phase I clinical study of OBX-115, Obsidian's lead engineered tumor infiltrating lymphocyte (TIL) therapy candidate.

21 Jul 2022

Unlocking the power of proteins to better understand human health

We speak to Andrew Lynn, the chief executive at Fluidic Analytics, about the role proteins play in understanding human disease.

From Fluidic Analytics 21 Jul 2022

Anti-SARS-CoV-2 nucleocapsid antibodies and pre-existing lung diseases may be independent predictors of long COVID

Researchers evaluated the incidence of long coronavirus disease (long COVID) in a demographically diverse population with different disease severities to inform clinicians and future vaccine development strategies.

21 Jul 2022

High-level resistance of SARS-CoV-2 BA.4 against neutralizing antibodies

Researchers evaluates the sensitivity of BA.4 in both vaccinated and unvaccinated individuals infected with the SARS-CoV-2 variants.

20 Jul 2022

COVID vaccines induce memory B and T cells in primary antibody deficient patients

The SARS-CoV-2-specific B- and T-cell response post-COVID-19 primary and booster vaccination in primary antibody deficient patients.

20 Jul 2022

Fourth dose of Pfizer mRNA COVID vaccine protective against variants and symptomatic infection

Researchers evaluate the efficacy of three- and four-dose regimens of a mRNA-based COVID-19 vaccine in reducing the risk of symptomatic infection.

20 Jul 2022

How the Omicron variant shifted the biology of SARS-CoV-2

Researchers discuss significant antigenic changes within the spike protein of new SARS-CoV-2 VOCs like the Omicron variant.

20 Jul 2022

How does vitamin D supplementation impact COVID-19 vaccine efficacy?

Researchers assessed the impact of vitamin D supplementation on the efficacy of SARS-CoV-2 vaccines.

20 Jul 2022

What is the prevalence of orthopoxviruses across different populations?

In a new study, researchers assessed the prevalence of orthopoxviruses among the general populations of Bolivia, France, Laos, and Mali.

20 Jul 2022

The clinical, epidemiological, and evolutionary consequences of a potential SARS-CoV-2-related bat virus spillover into humans

A team of scientists from France has recently described the epidemiological and clinical consequences of a bat sarbecovirus infection in humanized mice.

20 Jul 2022

Cholera variants need to be monitored closely to prevent outbreaks, scientists urge

Cholera variants are constantly evolving and need to be monitored closely to prevent outbreaks, say researchers.

20 Jul 2022

Antibodies News and Research

IUPUI researchers are developing a fast, efficient COVID-19 biosensor

LJI study about common cold coronaviruses may offer clues to how immunity can build up against SARS-CoV-2

New AI software can create proteins that may be useful as vaccines, cancer treatments

Study may help overcome some obstacles to the development of nanoparticle-based drugs

Alzheimer's disease and anti-amyloid therapeutic approaches

A different approach to build a more durable, broadly effective COVID-19 vaccine

Are Mexican free-tailed bats a SARS-CoV-2 reservoir?

Booster vaccination counters the severity of Omicron breakthrough infections

Immuno-infrared sensor identifies Alzheimer's disease in the blood up to 17 years in advance

FDA clears IND application for MD Anderson-sponsored Phase I clinical study of OBX-115 therapy

Unlocking the power of proteins to better understand human health

Anti-SARS-CoV-2 nucleocapsid antibodies and pre-existing lung diseases may be independent predictors of long COVID

High-level resistance of SARS-CoV-2 BA.4 against neutralizing antibodies

COVID vaccines induce memory B and T cells in primary antibody deficient patients

Fourth dose of Pfizer mRNA COVID vaccine protective against variants and symptomatic infection

How the Omicron variant shifted the biology of SARS-CoV-2

How does vitamin D supplementation impact COVID-19 vaccine efficacy?

What is the prevalence of orthopoxviruses across different populations?

The clinical, epidemiological, and evolutionary consequences of a potential SARS-CoV-2-related bat virus spillover into humans

Cholera variants need to be monitored closely to prevent outbreaks, scientists urge

Antibodies eBook

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Automating research - solutions and best practices

Latest Life Science News